DALLA VOLTA, ALBERTO
DALLA VOLTA, ALBERTO
Dipartimento di Scienze Cliniche e Sperimentali
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity
2017-01-01 Bedussi, Francesca; Galli, Diego; Fragni, Martina; Valcamonico, Francesca; Rossini, Elisa; DALLA VOLTA, Alberto; Vezzoli, Sara; Roca, Elisa; Ferrari, Vittorio; Lazzari, Barbara; Memo, Maurizio; Sigala, Sandra; Berruti, Alfredo
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation
2022-01-01 Bergamini, Marco; Dalla Volta, Alberto; Caramella, Irene; Bercich, Luisa; Fisogni, Simona; Bertoli, Mattia; Valcamonico, Francesca; Grisanti, Salvatore; Poliani, Pietro Luigi; Bertagna, Francesco; Berruti, Alfredo
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study
2022-01-01 Palumbo, Carlotta; Dalla Volta, Alberto; Zamboni, Stefania; Mazziotti, Gherardo; Zamparini, Manuel; Triggiani, Luca; Borghetti, Paolo; Maffezzoni, Filippo; Bresciani, Roberto; Rinaudo, Luca; Valcamonico, Francesca; Farina, Davide; Magrini, Stefano Maria; Antonelli, Alessandro; Simeone, Claudio; Berruti, Alfredo
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
2023-01-01 Volta, Alberto Dalla; Delbarba, Andrea; Valcamonico, Francesca; Cappelli, Carlo; Caramella, Irene; Bergamini, Marco; Ferlin, Alberto; Berruti, Alfredo
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
2022-01-01 Caramella, Irene; Dalla Volta, Alberto; Bergamini, Marco; Cosentini, Deborah; Valcamonico, Francesca; Berruti, Alfredo
Resistance to hormonal therapy in prostate cancer
2018-01-01 Berruti, A.; Dalla Volta, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity | 1-gen-2017 | Bedussi, Francesca; Galli, Diego; Fragni, Martina; Valcamonico, Francesca; Rossini, Elisa; DALLA VOLTA, Alberto; Vezzoli, Sara; Roca, Elisa; Ferrari, Vittorio; Lazzari, Barbara; Memo, Maurizio; Sigala, Sandra; Berruti, Alfredo | |
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation | 1-gen-2022 | Bergamini, Marco; Dalla Volta, Alberto; Caramella, Irene; Bercich, Luisa; Fisogni, Simona; Bertoli, Mattia; Valcamonico, Francesca; Grisanti, Salvatore; Poliani, Pietro Luigi; Bertagna, Francesco; Berruti, Alfredo | |
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study | 1-gen-2022 | Palumbo, Carlotta; Dalla Volta, Alberto; Zamboni, Stefania; Mazziotti, Gherardo; Zamparini, Manuel; Triggiani, Luca; Borghetti, Paolo; Maffezzoni, Filippo; Bresciani, Roberto; Rinaudo, Luca; Valcamonico, Francesca; Farina, Davide; Magrini, Stefano Maria; Antonelli, Alessandro; Simeone, Claudio; Berruti, Alfredo | |
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib | 1-gen-2023 | Volta, Alberto Dalla; Delbarba, Andrea; Valcamonico, Francesca; Cappelli, Carlo; Caramella, Irene; Bergamini, Marco; Ferlin, Alberto; Berruti, Alfredo | |
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question | 1-gen-2022 | Caramella, Irene; Dalla Volta, Alberto; Bergamini, Marco; Cosentini, Deborah; Valcamonico, Francesca; Berruti, Alfredo | |
Resistance to hormonal therapy in prostate cancer | 1-gen-2018 | Berruti, A.; Dalla Volta, A. |